NanoVibronix Inc., a medical technology company, has successfully closed a significant public offering of debt securities, specifically Series G Convertible Preferred Stock and Warrants. The offering included 400,000 shares of Preferred Stock, each with a par value of $0.001 and a stated value of $25, coupled with Warrants to purchase up to 4,901,982 shares of common stock at an exercise price of $2.04 per share. The offering generated gross proceeds of approximately $10 million. The funds will be used for redeeming outstanding debentures and notes, as well as for general corporate purposes. Further details and the final prospectus for the offering can be accessed at https://www.sec.gov.